Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland.
Aebi-Popp K, et al. J Virus Erad. 2016;2(1):52-54.
Karampatou A, et al. J Hepatol. 2018;68(1):33-41.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
U.S. Department of Health and Human Services, 2017.
Falade-Nwulia O, Sulkowski M. J Hepatol. 2017;66(2):267-269.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Centers for Disease Control and Prevention
Fact sheets for patients.
This webpage provides concise information regarding HCV risk, transmission, and prevention in people who inject drugs.
Updates in HCV Screening and Treatment
Key Issues Impacting OB/GYN Practice
|Faculty:||Nancy S. Reau, MD; Joanne L. Stone, MD, MSHCDL|